Bicycle Therapeutics (BCYC) Change in Account Payables (2018 - 2025)
Historic Change in Account Payables for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to -$5.1 million.
- Bicycle Therapeutics' Change in Account Payables fell 30920.1% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 29550.5%. This contributed to the annual value of $3.1 million for FY2024, which is 6132.22% down from last year.
- According to the latest figures from Q3 2025, Bicycle Therapeutics' Change in Account Payables is -$5.1 million, which was down 30920.1% from $6.1 million recorded in Q2 2025.
- Bicycle Therapeutics' Change in Account Payables' 5-year high stood at $10.7 million during Q4 2024, with a 5-year trough of -$5.9 million in Q1 2024.
- In the last 5 years, Bicycle Therapeutics' Change in Account Payables had a median value of -$255000.0 in 2022 and averaged $571789.5.
- Its Change in Account Payables has fluctuated over the past 5 years, first crashed by 68470.59% in 2023, then soared by 151508.12% in 2025.
- Quarter analysis of 5 years shows Bicycle Therapeutics' Change in Account Payables stood at $926000.0 in 2021, then tumbled by 355.94% to -$2.4 million in 2022, then skyrocketed by 275.82% to $4.2 million in 2023, then soared by 156.49% to $10.7 million in 2024, then tumbled by 147.44% to -$5.1 million in 2025.
- Its Change in Account Payables stands at -$5.1 million for Q3 2025, versus $6.1 million for Q2 2025 and -$5.0 million for Q1 2025.